23andMe Board resigns en masse amid CEO Anne Wojcicki's plans to take DNA testing company private
The board of directors at 23andMe, a leading DNA testing company, has resigned en masse amid disagreements over CEO Anne Wojcicki's plans to take the company private. The surprise move comes as Wojcicki seeks to take the company private in a deal valued at $4 billion.